News Zeposia Approved for Moderately to Severely Active Ulcerative Colitis Publish Date June 1, 2021 The FDA has approved Zeposia® (ozanimod) for moderately to severely active ulcerative colitis in adults.
Drugs in the Pipeline Dupilumab Under Review for Pediatric Asthma Publish Date March 4, 2021 The submission was based on data from the double-blind, placebo-controlled VOYAGE trial.
News Dupixent Prefilled Pen Approval Provides Additional Administration Option Publish Date June 22, 2020 The FDA has approved a prefilled pen formulation of Dupixent (dupilumab; Sanofi and Regeneron), providing another option for administering the treatment.